We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$16.7B
AUM Growth
+$2.27B
Cap. Flow
+$604M
Cap. Flow %
3.61%
Top 10 Hldgs %
17.4%
Holding
1,214
New
8
Increased
146
Reduced
104
Closed
19

Top Buys

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$103M
2
WB icon
Weibo
WB
+$88.7M
3
HLI icon
Houlihan Lokey
HLI
+$77.2M
4
PSN icon
Parsons
PSN
+$71M
5
DLTR icon
Dollar Tree
DLTR
+$50.2M

Sector Composition

Rank Sector Weight
1 Technology 20.4%
2 Financials 17.19%
3 Industrials 16.8%
4 Healthcare 12.66%
5 Consumer Discretionary 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
426
Emerson Electric
EMR
$84.2B
$24K ﹤0.01%
264
FEIM icon
427
Frequency Electronics
FEIM
$578M
$24K ﹤0.01%
2,100
OCFC icon
428
OceanFirst Financial
OCFC
$1.67B
$24K ﹤0.01%
1,000
SSP icon
429
E.W. Scripps
SSP
$258M
$24K ﹤0.01%
1,242
TT icon
430
Trane Technologies
TT
$101B
$24K ﹤0.01%
143
VRTX icon
431
Vertex Pharmaceuticals
VRTX
$121B
$24K ﹤0.01%
111
ALGN icon
432
Align Technology
ALGN
$12.2B
$23K ﹤0.01%
43
BIIB icon
433
Biogen
BIIB
$30.3B
$23K ﹤0.01%
82
BMRC icon
434
Bank of Marin Bancorp
BMRC
$476M
$23K ﹤0.01%
600
CTSH icon
435
Cognizant
CTSH
$24.9B
$23K ﹤0.01%
294
DG icon
436
Dollar General
DG
$28.1B
$23K ﹤0.01%
113
GGAL icon
437
Galicia Financial Group
GGAL
$8.12B
$23K ﹤0.01%
3,007
IDXX icon
438
Idexx Laboratories
IDXX
$44B
$23K ﹤0.01%
47
MCO icon
439
Moody's
MCO
$83.2B
$23K ﹤0.01%
78
PH icon
440
Parker-Hannifin
PH
$123B
$23K ﹤0.01%
73
REGN icon
441
Regeneron Pharmaceuticals
REGN
$77.6B
$23K ﹤0.01%
48
ROP icon
442
Roper Technologies
ROP
$38.9B
$23K ﹤0.01%
57
AE
443
DELISTED
Adams Resources & Energy Inc
AE
$23K ﹤0.01%
814
BAX icon
444
Baxter International
BAX
$13.6B
$22K ﹤0.01%
257
JCI icon
445
Johnson Controls International
JCI
$88.9B
$22K ﹤0.01%
365
KLAC icon
446
KLA
KLAC
$244B
$22K ﹤0.01%
670
MAR icon
447
Marriott International
MAR
$98.9B
$22K ﹤0.01%
148
NEM icon
448
Newmont
NEM
$98.8B
$22K ﹤0.01%
372
PEG icon
449
Public Service Enterprise Group
PEG
$38.4B
$22K ﹤0.01%
370
AIG icon
450
American International
AIG
$41.7B
$21K ﹤0.01%
446

Similar funds

EARNEST Partners's Q1 2021 Portfolio in Review

As of Q1 2021, EARNEST Partners held 1,214 positions worth $16.7B, up 16% from $14.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EARNEST Partners deployed $604M of net new capital in Q1 2021, opening 8 new positions and adding to 146 existing holdings. Its largest new stake was Meridian Bioscience Inc: 4,341,834 shares worth $114M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was FLIR Systems, Inc. (DE) Common Stock, an estimated $128M trimmed.

  • EARNEST Partners's largest Q1 2021 buy was Meridian Bioscience Inc: 4,341,834 shares worth $114M.
  • EARNEST Partners added most to Weibo in Q1 2021, an estimated $88.7M increase.
  • EARNEST Partners's biggest Q1 2021 reduction was FLIR Systems, Inc. (DE) Common Stock, cutting an estimated $128M.
  • EARNEST Partners fully exited Eaton Vance Corp. in Q1 2021, selling an estimated $77M.
  • EARNEST Partners's ten largest holdings make up 17% of its $16.7B portfolio in Q1 2021.
  • EARNEST Partners opened 8 new positions and closed 19 in Q1 2021.
  • EARNEST Partners's portfolio value rose 16% quarter-over-quarter to $16.7B.

Based on EARNEST Partners's 13F filing for Q1 2021, filed 17 May 2021.